| Overview |
| bs-4941R-FITC |
| PD-L1 Polyclonal Antibody, FITC Conjugated |
| WB, FCM |
| Human, Mouse, Rat |
| Cow, Pig, Horse, Rabbit |
| Specifications |
| FITC |
| Rabbit |
| KLH conjugated synthetic peptide derived from human CD274 |
| Polyclonal |
| #REF! |
| IgG |
| 1ug/ul |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Store at -20C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 29126 |
| Cell membrane |
| B7-H1; PD-L1; CD274; Programmed cell death 1 ligand 1; Programmed death ligand 1; PD-L1; PDCD1 ligand 1; B7 homolog 1; B7-H1; Programmed death ligand 1; PD1L1_HUMAN. |
| Programmed cell death 1 ligand 1(Programmed death ligand 1; PD-L1; PDCD1 ligand 1; B7 homolog 1; B7-H1; CD274) involved in the costimulatory signal, essential for T lymphocyte proliferation and production of IL10 and IFNG, in an IL2-dependent and a PDCD1-independent manner. Interaction with PDCD1 inhibit T-cell proliferation and cytokine production. |
| Application Dilution |
| WB |
1:300-5000 |
| FCM |
1:20-100 |